Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Non-small-cell lung carcinoma | D002289 | — | — | 1 | 5 | 2 | — | — | 8 |
Anthrax | D000881 | — | A22 | 2 | 4 | 1 | — | — | 7 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Malaria | D008288 | EFO_0001068 | B54 | 9 | 1 | — | — | — | 9 |
Melanoma | D008545 | — | — | 5 | 6 | — | — | — | 9 |
Lymphoma | D008223 | — | C85.9 | 6 | 5 | — | — | — | 8 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | 5 | — | — | — | 5 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 4 | 3 | — | — | — | 5 |
Falciparum malaria | D016778 | EFO_0007444 | B50 | 3 | 1 | — | — | — | 3 |
Mantle-cell lymphoma | D020522 | — | C83.1 | 2 | 2 | — | — | — | 3 |
Recurrence | D012008 | — | — | 2 | 2 | — | — | — | 3 |
B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 3 | 1 | — | — | — | 3 |
Pancreatic ductal carcinoma | D021441 | — | — | 2 | 1 | — | — | 1 | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Leukemia | D007938 | — | C95 | 3 | — | — | — | — | 3 |
Lymphoid leukemia | D007945 | — | C91 | 2 | — | — | — | — | 2 |
Multiple myeloma | D009101 | — | C90.0 | 2 | — | — | — | — | 2 |
Plasma cell neoplasms | D054219 | — | — | 2 | — | — | — | — | 2 |
Plasmacytoma | D010954 | — | C90.3 | 2 | — | — | — | — | 2 |
Neoplasms | D009369 | — | C80 | 2 | — | — | — | — | 2 |
Human influenza | D007251 | EFO_0007328 | J11.1 | 1 | — | — | — | — | 1 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 1 | — | — | — | — | 1 |
Bile duct neoplasms | D001650 | — | — | 1 | — | — | — | — | 1 |
Residual neoplasm | D018365 | — | — | 1 | — | — | — | — | 1 |
Drug common name | Agatolimod |
INN | agatolimod |
Description | Agatolimod (also known as CpG 7909, ODN 2006, PF-3512676, VaxImmune, and ProMuneT) is a CpG Oligodeoxynucleotide which acts as a toll-like receptor 9 agonist. Agatolimod stimulates the immune system and has been tested for prevention and treatment of cancer, infectious diseases, allergies, and asthma.
|
Classification | Oligonucleotide |
Drug class | immunomodulators: immunomodulators, toll-like receptor agonists |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | Cc1cn([C@H]2C[C@H](O)[C@@H](COP(O)(=S)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3CO)O2)c(=O)[nH]c1=O |
PDB | — |
CAS-ID | 541547-35-7 |
RxCUI | — |
ChEMBL ID | CHEMBL2103792 |
ChEBI ID | — |
PubChem CID | 56841789 |
DrugBank | — |
UNII ID | 5V336PV3HG (ChemIDplus, GSRS) |